Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Hes1 ELISA Kit (AC3705)
Cat.#: ASET-2294
Specifications
Description Human Hes1 ELISA Kit allows for the in vitro quantitative determination of human Hes1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2502 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3913) Quantitative inquiry ASET-2270 Human Insulin ELISA Kit (AC3681) Quantitative inquiry ASET-1527 Mouse Neuropeptide Y ELISA Kit (AC2938) Quantitative inquiry ASET-1679 Human Synaptogyrin 3 ELISA Kit (AC3090) Quantitative inquiry ASET-1569 Rat alpha MSH ELISA Kit (AC2980) Quantitative inquiry ASET-2234 Human Cx30 ELISA Kit (AC3645) Quantitative inquiry ASET-2425 Human DYRK1A ELISA Kit (AC3836) Quantitative inquiry ASET-1146 Human Urocortin ELISA Kit (AC2557) Quantitative inquiry ASET-1221 Human PTN ELISA Kit (AC2632) Quantitative inquiry ASET-2469 Mouse Npffr2 ELISA Kit (AC3880) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket